JP2018516944A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516944A5 JP2018516944A5 JP2017563314A JP2017563314A JP2018516944A5 JP 2018516944 A5 JP2018516944 A5 JP 2018516944A5 JP 2017563314 A JP2017563314 A JP 2017563314A JP 2017563314 A JP2017563314 A JP 2017563314A JP 2018516944 A5 JP2018516944 A5 JP 2018516944A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- motomeko
- complement
- gvhd
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1410116.6A GB201410116D0 (en) | 2014-06-06 | 2014-06-06 | Method of treatment |
| PCT/EP2015/062742 WO2015185760A1 (en) | 2014-06-06 | 2015-06-08 | Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism |
| EPPCT/EP2015/062742 | 2015-06-08 | ||
| PCT/EP2015/079172 WO2016198133A1 (en) | 2015-06-08 | 2015-12-09 | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018516944A JP2018516944A (ja) | 2018-06-28 |
| JP2018516944A5 true JP2018516944A5 (OSRAM) | 2019-01-24 |
| JP6767396B2 JP6767396B2 (ja) | 2020-10-14 |
Family
ID=51266841
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016571246A Active JP7045133B2 (ja) | 2014-06-06 | 2015-06-08 | Ｃ５多型を有する患者における補体媒介性疾患の治療に使用するためのオルニトドロス・モウバタ（Ｏｒｎｉｔｈｏｄｏｒｏｓ ｍｏｕｂａｔａ）補体阻害剤 |
| JP2017563314A Expired - Fee Related JP6767396B2 (ja) | 2014-06-06 | 2015-12-09 | 急性移植片対宿主病の治療に使用するためのオルニトドロス・モウバタ補体阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016571246A Active JP7045133B2 (ja) | 2014-06-06 | 2015-06-08 | Ｃ５多型を有する患者における補体媒介性疾患の治療に使用するためのオルニトドロス・モウバタ（Ｏｒｎｉｔｈｏｄｏｒｏｓ ｍｏｕｂａｔａ）補体阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11052129B2 (OSRAM) |
| EP (1) | EP3151851B1 (OSRAM) |
| JP (2) | JP7045133B2 (OSRAM) |
| KR (1) | KR102439717B1 (OSRAM) |
| CN (1) | CN106659767B (OSRAM) |
| AU (1) | AU2015270396B2 (OSRAM) |
| BR (1) | BR112016028446A2 (OSRAM) |
| CA (1) | CA2951175A1 (OSRAM) |
| DK (2) | DK3151851T3 (OSRAM) |
| ES (2) | ES2906630T3 (OSRAM) |
| GB (1) | GB201410116D0 (OSRAM) |
| IL (1) | IL249237B (OSRAM) |
| MX (1) | MX382757B (OSRAM) |
| PL (2) | PL3151851T3 (OSRAM) |
| RU (1) | RU2700932C2 (OSRAM) |
| WO (1) | WO2015185760A1 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016198133A1 (en) * | 2015-06-08 | 2016-12-15 | Volution Immuno Pharmaceuticals Sa | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease |
| GB201410116D0 (en) * | 2014-06-06 | 2014-07-23 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| GB201602802D0 (en) * | 2016-02-17 | 2016-03-30 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US20190225678A1 (en) * | 2016-06-07 | 2019-07-25 | Novartis Ag | Anti-c5 antibody for treating patients with complement c5 polymorphism |
| SE540754C2 (en) * | 2016-11-30 | 2018-10-30 | Ikea Supply Ag | Molding of fiber blanks into three-dimensional fiber block |
| EP3612206A1 (en) * | 2017-04-21 | 2020-02-26 | Volution Immuno Pharmaceuticals SA | Coversin for the treatment of cicatrising eye inflammatory disorders |
| DK3612208T5 (da) | 2017-04-21 | 2024-09-02 | Volution Immuno Pharmaceuticals Sa | Coversin til behandlingen af autoimmune sygdomme med blisterdannelse |
| WO2019186084A1 (en) * | 2018-03-26 | 2019-10-03 | The University Of Liverpool | Anti-complement histones |
| US20220047673A1 (en) * | 2018-09-10 | 2022-02-17 | Volution Immuno Pharmaceuticals Sa | Coversin for Use in the Treatment of Rheumatic Diseases |
| GB201905810D0 (en) * | 2019-04-25 | 2019-06-05 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| GB202218084D0 (en) | 2022-12-01 | 2023-01-18 | Volution Immuno Pharmaceuticals Sa | Fusion proteins |
| GB202408081D0 (en) | 2024-06-06 | 2024-07-24 | Volution Immuno Pharmaceuticals Sa | Methods of removing impurities |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050054033A9 (en) | 1995-08-30 | 2005-03-10 | Human Genome Sciences, Inc. | Methods and compositions for treating and preventing infection using human interferon regulatory factor 3 |
| GB0312619D0 (en) * | 2003-06-02 | 2003-07-09 | Evolutec Ltd | Complement inhibitors |
| MXPA05012880A (es) | 2003-06-02 | 2006-02-22 | Evolutec Ltd | Inhibidores de complemento. |
| GB0518443D0 (en) * | 2005-09-09 | 2005-10-19 | Evolutec Ltd | Method of treating myasthenia gravis |
| JP2010502687A (ja) | 2006-09-08 | 2010-01-28 | ヴァーレイ・リミテッド | 呼吸器疾患の治療方法 |
| GB0617734D0 (en) * | 2006-09-08 | 2006-10-18 | Evolutec Ltd | Method of treating peripheral nerve disorders |
| GB0802116D0 (en) * | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
| GB0906779D0 (en) | 2009-04-20 | 2009-06-03 | Natural Environment Res Council | Composition |
| CN102762223B (zh) * | 2010-01-08 | 2014-09-03 | 沃卢申伊谬诺制药公司 | 用于治疗呼吸道病毒性感染的ev576 |
| TW201418707A (zh) * | 2012-09-21 | 2014-05-16 | Alexion Pharma Inc | 補體組分ｃ５拮抗劑之篩選分析 |
| GB201410116D0 (en) | 2014-06-06 | 2014-07-23 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| DK3612208T5 (da) | 2017-04-21 | 2024-09-02 | Volution Immuno Pharmaceuticals Sa | Coversin til behandlingen af autoimmune sygdomme med blisterdannelse |
-
2014
- 2014-06-06 GB GBGB1410116.6A patent/GB201410116D0/en not_active Ceased
-
2015
- 2015-06-08 MX MX2016016139A patent/MX382757B/es unknown
- 2015-06-08 DK DK15728491.0T patent/DK3151851T3/da active
- 2015-06-08 RU RU2016151179A patent/RU2700932C2/ru active
- 2015-06-08 CN CN201580040646.5A patent/CN106659767B/zh active Active
- 2015-06-08 PL PL15728491T patent/PL3151851T3/pl unknown
- 2015-06-08 BR BR112016028446A patent/BR112016028446A2/pt active Search and Examination
- 2015-06-08 WO PCT/EP2015/062742 patent/WO2015185760A1/en not_active Ceased
- 2015-06-08 US US15/315,136 patent/US11052129B2/en active Active
- 2015-06-08 JP JP2016571246A patent/JP7045133B2/ja active Active
- 2015-06-08 ES ES15728491T patent/ES2906630T3/es active Active
- 2015-06-08 AU AU2015270396A patent/AU2015270396B2/en not_active Ceased
- 2015-06-08 CA CA2951175A patent/CA2951175A1/en active Pending
- 2015-06-08 EP EP15728491.0A patent/EP3151851B1/en active Active
- 2015-06-08 KR KR1020167036998A patent/KR102439717B1/ko active Active
- 2015-12-09 JP JP2017563314A patent/JP6767396B2/ja not_active Expired - Fee Related
- 2015-12-09 PL PL15807907T patent/PL3302519T3/pl unknown
- 2015-12-09 US US15/577,906 patent/US20180193417A1/en not_active Abandoned
- 2015-12-09 ES ES15807907T patent/ES2906632T3/es active Active
- 2015-12-09 DK DK15807907.9T patent/DK3302519T3/da active
-
2016
- 2016-11-27 IL IL249237A patent/IL249237B/en active IP Right Grant
-
2021
- 2021-05-28 US US17/333,675 patent/US20210283221A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018516944A5 (OSRAM) | ||
| Speer et al. | Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2 | |
| Chamorro et al. | The immunology of acute stroke | |
| JP5759445B2 (ja) | 病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物 | |
| JP6992201B2 (ja) | 合成ペプチド化合物及び使用方法 | |
| AU2019314383B2 (en) | Engineered hemichannels, engineered vesicles, and uses thereof | |
| JP2017518316A5 (OSRAM) | ||
| Sacks et al. | Targeting complement at the time of transplantation | |
| JP2016531910A5 (OSRAM) | ||
| JP2011528332A (ja) | 哺乳動物ベータ・デフェンシンを用いた炎症性疾患の処置 | |
| JP2015522264A5 (OSRAM) | ||
| WO2011149964A3 (en) | Methods for treating or preventing vascular graft failure | |
| JP2019533722A5 (OSRAM) | ||
| JPWO2019107530A5 (OSRAM) | ||
| JP2015510393A5 (OSRAM) | ||
| US20220048948A1 (en) | Cd40 targeted peptides and uses thereof | |
| JP2017522288A5 (OSRAM) | ||
| WO2019213686A1 (en) | Therapeutic compositions and uses therefor | |
| WO2016044493A1 (en) | Compositions and methods for treating acute radiation syndrome | |
| EA202190310A1 (ru) | Белок для лечения воспалительных заболеваний | |
| JP2019508175A5 (OSRAM) | ||
| WO2013130499A1 (en) | Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment | |
| AU2016317574A1 (en) | Compositions and methods for the treatment of neurodamage | |
| JP2010533660A5 (OSRAM) | ||
| RU2649760C1 (ru) | Способ лечения острого инфаркта миокарда с подъемом сегмента ST, осложненного кардиогенным шоком |